Cargando…

Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity

BACKGROUND: Co-Activator Arginine Methyltransferase 1(CARM1) is an Estrogen Receptor (ER) cofactor that remodels chromatin for gene regulation via methylation of Histone3. We investigated CARM1 levels and localization across breast cancer tumors in a cohort of patients of either European or African...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Melissa B, Liu, Xinyu, Wang, Shiyao, Reeves, Jaxk, Khramtsov, Andrey, Huo, Dezheng, Olopade, Olufunmilayo I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663705/
https://www.ncbi.nlm.nih.gov/pubmed/23663560
http://dx.doi.org/10.1186/1476-4598-12-40
_version_ 1782271023796715520
author Davis, Melissa B
Liu, Xinyu
Wang, Shiyao
Reeves, Jaxk
Khramtsov, Andrey
Huo, Dezheng
Olopade, Olufunmilayo I
author_facet Davis, Melissa B
Liu, Xinyu
Wang, Shiyao
Reeves, Jaxk
Khramtsov, Andrey
Huo, Dezheng
Olopade, Olufunmilayo I
author_sort Davis, Melissa B
collection PubMed
description BACKGROUND: Co-Activator Arginine Methyltransferase 1(CARM1) is an Estrogen Receptor (ER) cofactor that remodels chromatin for gene regulation via methylation of Histone3. We investigated CARM1 levels and localization across breast cancer tumors in a cohort of patients of either European or African ancestry. METHODS: We analyzed CARM1 levels using tissue microarrays with over 800 histological samples from 549 female cancer patients from the US and Nigeria, Africa. We assessed associations between CARM1 expression localized to the nucleus and cytoplasm for 11 distinct variables, including; ER status, Progesterone Receptor status, molecular subtypes, ethnicity, HER2+ status, other clinical variables and survival. RESULTS: We found that levels of cytoplasmic CARM1 are distinct among tumor sub-types and increased levels are associated with ER-negative (ER-) status. Higher nuclear CARM1 levels are associated with HER2 receptor status. EGFR expression also correlates with localization of CARM1 into the cytoplasm. This suggests there are distinct functions of CARM1 among molecular tumor types. Our data reveals a basal-like subtype association with CARM1, possibly due to expression of Epidermal Growth Factor Receptor (EGFR). Lastly, increased cytoplasmic CARM1, relative to nuclear levels, appear to be associated with self-identified African ethnicity and this result is being further investigated using quantified genetic ancestry measures. CONCLUSIONS: Although it is known to be an ER cofactor in breast cancer, CARM1 expression levels are independent of ER. CARM1 has distinct functions among molecular subtypes, as is indicative of its sub-cellular localization and it may function in subtype etiology. These sub-cellular localization patterns, indicate a novel role beyond its ER cofactor function in breast cancer. Differential localization among ethnic groups may be due to ancestry-specific polymorphisms which alter the gene product.
format Online
Article
Text
id pubmed-3663705
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36637052013-05-25 Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity Davis, Melissa B Liu, Xinyu Wang, Shiyao Reeves, Jaxk Khramtsov, Andrey Huo, Dezheng Olopade, Olufunmilayo I Mol Cancer Research BACKGROUND: Co-Activator Arginine Methyltransferase 1(CARM1) is an Estrogen Receptor (ER) cofactor that remodels chromatin for gene regulation via methylation of Histone3. We investigated CARM1 levels and localization across breast cancer tumors in a cohort of patients of either European or African ancestry. METHODS: We analyzed CARM1 levels using tissue microarrays with over 800 histological samples from 549 female cancer patients from the US and Nigeria, Africa. We assessed associations between CARM1 expression localized to the nucleus and cytoplasm for 11 distinct variables, including; ER status, Progesterone Receptor status, molecular subtypes, ethnicity, HER2+ status, other clinical variables and survival. RESULTS: We found that levels of cytoplasmic CARM1 are distinct among tumor sub-types and increased levels are associated with ER-negative (ER-) status. Higher nuclear CARM1 levels are associated with HER2 receptor status. EGFR expression also correlates with localization of CARM1 into the cytoplasm. This suggests there are distinct functions of CARM1 among molecular tumor types. Our data reveals a basal-like subtype association with CARM1, possibly due to expression of Epidermal Growth Factor Receptor (EGFR). Lastly, increased cytoplasmic CARM1, relative to nuclear levels, appear to be associated with self-identified African ethnicity and this result is being further investigated using quantified genetic ancestry measures. CONCLUSIONS: Although it is known to be an ER cofactor in breast cancer, CARM1 expression levels are independent of ER. CARM1 has distinct functions among molecular subtypes, as is indicative of its sub-cellular localization and it may function in subtype etiology. These sub-cellular localization patterns, indicate a novel role beyond its ER cofactor function in breast cancer. Differential localization among ethnic groups may be due to ancestry-specific polymorphisms which alter the gene product. BioMed Central 2013-05-10 /pmc/articles/PMC3663705/ /pubmed/23663560 http://dx.doi.org/10.1186/1476-4598-12-40 Text en Copyright © 2013 Davis et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Davis, Melissa B
Liu, Xinyu
Wang, Shiyao
Reeves, Jaxk
Khramtsov, Andrey
Huo, Dezheng
Olopade, Olufunmilayo I
Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity
title Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity
title_full Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity
title_fullStr Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity
title_full_unstemmed Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity
title_short Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity
title_sort expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (carm1), is associated with specific breast cancer subtypes and ethnicity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663705/
https://www.ncbi.nlm.nih.gov/pubmed/23663560
http://dx.doi.org/10.1186/1476-4598-12-40
work_keys_str_mv AT davismelissab expressionandsubcellularlocalizationofanepigeneticregulatorcoactivatorargininemethyltransferase1carm1isassociatedwithspecificbreastcancersubtypesandethnicity
AT liuxinyu expressionandsubcellularlocalizationofanepigeneticregulatorcoactivatorargininemethyltransferase1carm1isassociatedwithspecificbreastcancersubtypesandethnicity
AT wangshiyao expressionandsubcellularlocalizationofanepigeneticregulatorcoactivatorargininemethyltransferase1carm1isassociatedwithspecificbreastcancersubtypesandethnicity
AT reevesjaxk expressionandsubcellularlocalizationofanepigeneticregulatorcoactivatorargininemethyltransferase1carm1isassociatedwithspecificbreastcancersubtypesandethnicity
AT khramtsovandrey expressionandsubcellularlocalizationofanepigeneticregulatorcoactivatorargininemethyltransferase1carm1isassociatedwithspecificbreastcancersubtypesandethnicity
AT huodezheng expressionandsubcellularlocalizationofanepigeneticregulatorcoactivatorargininemethyltransferase1carm1isassociatedwithspecificbreastcancersubtypesandethnicity
AT olopadeolufunmilayoi expressionandsubcellularlocalizationofanepigeneticregulatorcoactivatorargininemethyltransferase1carm1isassociatedwithspecificbreastcancersubtypesandethnicity